Transforming Pediatric Cancer Care in Pakistan

Pakistan is entering a new chapter in healthcare as hospitals across the country prepare to receive free childhood cancer medicines in 2026. This initiative, launched under a landmark agreement between the Government of Pakistan and the World Health Organization (WHO), promises to bring hope to thousands of families battling pediatric cancer.

Four hospitals are finalizing preparations to receive the first batch of medicines before the end of 2026. Meanwhile, seven additional centers are working toward readiness by 2027. These facilities are upgrading infrastructure, training staff, and implementing international protocols to ensure smooth delivery and effective use of the medicines.

The program is supported by St. Jude Children’s Research Hospital, whose experts have visited hospitals such as Noori Hospital in Islamabad to provide guidance and recommendations. Their involvement ensures that the medicines are not only delivered but also integrated into a system that prioritizes quality care and patient safety.

This initiative is part of the Global Platform for Access to Childhood Cancer Medicines, which aims to make life‑saving treatments available to countries with limited resources. In Pakistan, where more than 8,000 new pediatric cancer cases are diagnosed each year, the program could significantly improve survival rates and reduce the burden on families.

By combining international expertise with local commitment, Pakistan is positioning itself to transform pediatric oncology. The arrival of free childhood cancer medicines marks a turning point — one that could redefine healthcare access and outcomes for the nation’s youngest patients.